cefpodoxime
UkraineDrugs containing this active substance
-
The drug is used to treat infections caused by bacteria sensitive to it. Specifically, it is prescribed for ENT infections (sinusitis, tonsillitis, pharyngitis), respiratory tract infections (pneumonia, bronchitis), urinary tract infections, skin and soft tissue infections, as well as for gonorrhea.
Form: tablets, film-coated
Active substance Dosage cefpodoxime 200 mg ATC: J01DD13
Manufacturer: Aurobindo Pharma Ltd. Unit VI, Block D
-
The drug is used to treat infections of the ENT organs (sinusitis, tonsillitis, pharyngitis), respiratory tract infections (pneumonia, bronchitis), urinary tract infections, skin and soft tissue infections (abscesses, wounds, ulcers), as well as for the treatment of gonorrhea.
Form: tablets, film-coated
Active substance Dosage cefpodoxime 100 mg ATC: J01DD13
Manufacturer: Aurobindo Pharma Ltd. Unit VI, Block D
-
The drug is used to treat mild to moderate infections, such as sinusitis, tonsillitis, pharyngitis, pneumonia, exacerbation of chronic bronchitis, skin infections, urinary tract infections (cystitis, pyelonephritis), and gonorrhea.
Form: tablets, film-coated
Active substance Dosage cefpodoxime 100 mg ATC: J01DD13
Manufacturer: Aurobindo Pharma Ltd. Unit VI, Block D
-
The drug is used to treat infections caused by susceptible bacteria: ENT infections (otitis, sinusitis, tonsillitis, pharyngitis), respiratory tract infections (pneumonia, bronchitis), uncomplicated urinary tract infections, as well as skin and soft tissue infections (abscesses, furuncles, infected wounds, etc.).
Form: powder for oral suspension
Active substance Dosage cefpodoxime 40 mg/5 ml ATC: J01DD13
Manufacturer: Aurobindo Pharma Ltd. Unit VI, Block D
-
The drug is used to treat mild to moderate infections, such as sinusitis, tonsillitis, pharyngitis, pneumonia, exacerbation of chronic bronchitis, skin infections, urinary tract infections (cystitis, pyelonephritis), and gonorrhea.
Form: tablets, film-coated
Active substance Dosage cefpodoxime 200 mg ATC: J01DD13
Manufacturer: Aurobindo Pharma Ltd. Unit VI, Block D
-
The drug is used to treat infections caused by bacteria sensitive to it. Specifically, it is prescribed for infections of the ENT organs (sinusitis, tonsillitis, pharyngitis), respiratory tract (bronchitis, pneumonia), urinary tract (cystitis, pyelonephritis), skin and soft tissue infections, as well as uncomplicated gonococcal urethritis.
Form: tablets, film-coated
Active substance Dosage cefpodoxime 200 mg ATC: J01DD13
Manufacturer: Sandoz GmbH - Anti-Infectives GLZ and Chemical Operations Kundl (AIXO GLZ Kundl)
-
The drug is used to treat infections caused by susceptible bacteria. Specifically, it is indicated for the treatment of ENT infections (sinusitis, tonsillitis, otitis), respiratory tract infections (pneumonia, bronchitis), urinary tract infections, as well as skin and soft tissue infections.
Form: powder for oral suspension
Active substance Dosage cefpodoxime 40 mg/5 ml ATC: J01DD13
Manufacturer: Salutas Pharma GmbH (secondary packaging)
-
The drug is used to treat infections caused by susceptible bacteria. Specifically, it is prescribed for ENT diseases (otitis, sinusitis, tonsillitis, pharyngitis), respiratory tract infections (pneumonia, bronchitis), urinary tract infections, as well as skin and soft tissue infections (abscesses, boils, infected wounds).
Form: powder for oral suspension
Active substance Dosage cefpodoxime 50 mg/5 ml ATC: J01DD13
Manufacturer: Pharma International Company
-
The drug is used to treat infections caused by susceptible bacteria: ENT infections (otitis, sinusitis, tonsillitis, pharyngitis), respiratory tract infections (pneumonia, bronchitis), urinary tract infections (cystitis, pyelonephritis), as well as skin and soft tissue infections (abscesses, furuncles, wounds).
Form: powder for oral suspension
Active substance Dosage cefpodoxime 100 mg/5 ml ATC: J01DD13
Manufacturer: Pharma International Company
-
The drug is used to treat infections caused by susceptible bacteria, specifically infections of the ENT organs (sinusitis, tonsillitis, pharyngitis), respiratory tract (bronchitis, pneumonia), urinary tract (cystitis, pyelonephritis), skin and soft tissues, as well as uncomplicated gonococcal urethritis.
Form: tablets, film-coated
Active substance Dosage cefpodoxime 100 mg ATC: J01DD13
Manufacturer: Pharma International Company
-
The drug is used to treat infections caused by susceptible bacteria, specifically infections of the ENT organs (sinusitis, tonsillitis, pharyngitis), respiratory tract (bronchitis, pneumonia), urinary tract (cystitis, pyelonephritis), skin and soft tissues, as well as uncomplicated gonococcal urethritis.
Form: tablets, film-coated
Active substance Dosage cefpodoxime 200 mg ATC: J01DD13
Manufacturer: Pharma International Company
-
The drug is used to treat infections of the ENT organs (sinusitis, tonsillitis, pharyngitis), respiratory tract (bronchitis, pneumonia), urinary tract (cystitis, pyelonephritis), as well as skin and soft tissue infections and gonococcal urethritis.
Form: tablets, film-coated
Active substance Dosage cefpodoxime 200 mg ATC: J01DD13
Manufacturer: NOBEL ILAC SANAYI VE TICARET A.S.
-
The drug is used to treat infections caused by susceptible bacteria. Specifically, it is prescribed for diseases of the ENT organs (sinusitis, tonsillitis, pharyngitis), respiratory tract (bronchitis, pneumonia), urinary tract infections, skin and soft tissue infections (abscesses, furuncles, wounds), as well as gonococcal urethritis.
Form: tablets, film-coated
Active substance Dosage cefpodoxime 100 mg ATC: J01DD13
Manufacturer: Lupin Limited
-
The drug is used to treat infections caused by susceptible bacteria. Specifically, it is applied for diseases of the ENT organs (sinusitis, tonsillitis, pharyngitis), respiratory tract (bronchitis, pneumonia), urinary tract infections, skin, soft tissues, and gonococcal urethritis.
Form: tablets, film-coated
Active substance Dosage cefpodoxime 200 mg ATC: J01DD13
Manufacturer: Lupin Limited
-
The drug is used to treat infections of the ENT organs (sinusitis, tonsillitis, pharyngitis), respiratory tract (bronchitis, pneumonia), urinary tract infections, skin and soft tissue infections, as well as gonococcal urethritis.
Form: tablets, film-coated
Active substance Dosage cefpodoxime 100 mg ATC: J01DD13
Manufacturer: ALKALOID AD Skopje (secondary packaging; batch release)
-
The drug is used to treat infections caused by susceptible bacteria. Specifically, it is prescribed for ENT infections (otitis, sinusitis, tonsillitis, pharyngitis), respiratory tract infections (pneumonia, bronchitis), urinary tract infections, as well as skin and soft tissue infections.
Form: powder for oral suspension
Active substance Dosage cefpodoxime 40 mg/5 ml ATC: J01DD13
Manufacturer: ALKALOID AD Skopje (secondary packaging: batch release)
-
The drug is used to treat infections of the ENT organs (sinusitis, tonsillitis, pharyngitis), respiratory tract (bronchitis, pneumonia), urinary tract infections, skin and soft tissue infections, as well as gonococcal urethritis.
Form: tablets, film-coated
Active substance Dosage cefpodoxime 200 mg ATC: J01DD13
Manufacturer: ALKALOID AD Skopje (secondary packaging; batch release)
-
The drug is used to treat adults with the following infections: tonsillitis, acute sinusitis, acute bronchitis, exacerbation of chronic bronchitis, and bacterial pneumonia.
Form: tablets, film-coated
Active substance Dosage cefpodoxime 100 mg ATC: J01DD13
Manufacturer: Sai Parenterals Limited
-
The drug is used to treat adults with tonsillitis, acute sinusitis, acute bronchitis, exacerbation of chronic bronchitis, and bacterial pneumonia.
Form: tablets, film-coated
Active substance Dosage cefpodoxime 200 mg ATC: J01DD13
Manufacturer: Sai Parenterals Limited